Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
PharmAla signs definitive agreement with Jupiter Neurosciences to out-license their patented ALA-002 molecule, securing up-front and development payments.
-
Innovation in advanced materials and infrastructure took center stage as investors watch $XERI, $ARLSF, $ARE, $SLND
-
Argo Graphene Solutions (CSE: ARGO) (OTCQB: ARLSF) (FSE: 94Y) appointed Dr. Vikas Berry as Chief Executive Officer of the Company.
-
Nucleome Therapeutics strengthens global IP portfolio with US patent for MCC Technology, the central technology of Nucleome’s 3D genomics platform.
-
Adeia to Release Second Quarter 2026 Financial Results on August 3, 2026
-
Anaqua has announced the renewal of its partnership with Sony to strengthen intellectual property as a core driver of Sony's business strategy and growth.
-
東京, July 08, 2026 (GLOBE NEWSWIRE) -- －...
-
Adeia Initiates Patent Infringement Litigation Against Fubo
-
France Licensing Day 2026 broke records with 550+ attendees & 55 exhibitors in Paris on June 30, highlighting France's growing licensing market
-
Adeia Enters into Multi-Year IP License Agreement with RPX